Eastwood Bio-Medical Canada Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EWOOF research report →
Companywww.eleotin.ca
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity.
- CEO
- Youngsoo Kim
- IPO
- 2018
- HQ
- Richmond, BC, CA
Price Chart
Valuation
- Market Cap
- $47.79M
- P/E
- -120.17
- P/S
- 75.67
- P/B
- -78.13
- EV/EBITDA
- -160.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.18%
- Op Margin
- -58.21%
- Net Margin
- -62.98%
- ROE
- 96.32%
- ROIC
- 64.87%
Growth & Income
- Revenue
- $867.94K · -33.22%
- Net Income
- $-546,598 · -264.69%
- EPS
- $-0.01 · -185.00%
- Op Income
- $-505,202
- FCF YoY
- -131.37%
Performance & Tape
- 52W High
- $0.69
- 52W Low
- $0.69
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.28
- Avg Volume
- 0
Get TickerSpark's AI analysis on EWOOF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EWOOF Coverage
We haven't published any research on EWOOF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EWOOF Report →